Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent
United Kingdom

Date of acknowledgement from the Member State Competent Authority

Title of the Project
A Phase I, randomised, double-blind, placebo-controlled, parallel group dose escalation study to evaluate the safety, tolerability and immunogenicity of three doses of a potential oral enteric fever vaccine (ZH9 + ZH9PA) in healthy subjects 18 to 45 years of age.

Proposed period of release:
01/09/2019 to 30/09/2021

Name of the Institute(s) or Company(ies)
Prokarium Ltd., ;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:

Identity of the GMO:
Genus: Salmonella
Species: enterica

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known